Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...
Key Takeaways. Draft guidance targets reduction/elimination of nonhuman primate testing for monoclonal antibodies, signaling higher regulatory receptivity to alternative nonclinic ...
VivoSim Labs has launched non-animal toxicology models to enhance drug development, aligning with FDA's initiative to phase out animal testing. VivoSim Labs, Inc. has officially launched after ...
Add Yahoo as a preferred source to see more of our stories on Google. This week, the Trump administration released new draft guidance meant to steer drugmakers toward alternatives to animal testing. - ...
The VICT3R project is expanding its consortium by adding new beneficiaries and organisations to the network of contract research organisations (CROs) associated with the project. This expansion ...
Experts from the Physicians Committee for Responsible Medicine traveled to San Diego, California, to attend the 2026 Society of Toxicology Annual Meeting to advance our work accelerating the ...
This Research Topic will showcase advances in non-animal toxicology that improve the mechanistic understanding and predictive assessment of chemical safety.
The FDA has released a plan to stop or reduce the use of primates for testing the safety of certain monoclonal antibodies (mAbs), the latest expansion of the regulator’s efforts to eliminate animal ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of animals each year are killed in U.S. laboratories as part of medical training and chemical, food, drug and ...
The U.S. Environmental Protection Agency formalized several policy recommendations designed to reduce animal tests in pesticide safety. Even though progress has been made in developing non-animal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results